Compare BIO & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | XPEV |
|---|---|---|
| Founded | 1952 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Auto Manufacturing |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 12.5B |
| IPO Year | 1994 | 2020 |
| Metric | BIO | XPEV |
|---|---|---|
| Price | $378.68 | $10.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $339.75 | $23.08 |
| AVG Volume (30 Days) | 243.5K | ★ 5.8M |
| Earning Date | 04-30-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,583,200,000.00 | N/A |
| Revenue This Year | $2.74 | $25.76 |
| Revenue Next Year | $3.20 | $25.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $236.73 | $10.16 |
| 52 Week High | $396.23 | $28.20 |
| Indicator | BIO | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 33.57 |
| Support Level | $364.41 | N/A |
| Resistance Level | $396.23 | $10.84 |
| Average True Range (ATR) | 9.50 | 0.23 |
| MACD | -1.39 | 0.01 |
| Stochastic Oscillator | 57.47 | 5.15 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.